This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Pacira Pharmaceuticals Inc (PCRX)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash and Equivalents 12.52M 10.13M 46.17M 26.13M
Receivables 14.59M 4.35M 2.11M 1.19M
Inventories 15.56M 12.08M 1.24M 1.60M
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 106.75M 60.92M 82.65M 31.06M
Property, Plant & Equipment, Gross 60.76M 50.72M 33.38M 30.02M
Accumulated Depreciation & Depletion 12.58M 11.60M 8.28M 6.07M
Property, Plant & Equipment, Net 48.18M 39.12M 25.10M 23.95M
Intangibles 1.16M 3.21M 5.26M 8.91M
Other Non-Current Assets 3.40M 511.00K 479.00K 2.64M
Total Non-Current Assets 63.07M 51.13M 30.84M 35.51M
Liabilities & Shareholder Equity
Total Assets 169.82M 112.05M 113.49M 66.56M
Accounts Payable 3.07M 2.57M 3.44M 6.04M
Short Term Debt 0.00 0.00 8.26M 3.18M
Other Current Liabilities 1.02M 823.00K 0.00 1.58M
Total Current Liabilities 121.94M 14.16M 31.91M 16.32M
Long Term Debt 0.00 25.19M 18.54M 21.87M
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 6.63M 6.85M 13.24M 76.75M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 6.63M 32.04M 33.31M 98.62M
Total Liabilities 128.57M 46.20M 65.22M 114.94M
Preferred Stock Equity 0.00 0.00 0.00 6.00K
Common Stock Equity 41.25M 65.86M 48.27M -48.39M
Common Par 34.00K 33.00K 25.00K 1.00K
Additional Paid In Capital 337.64M 298.32M 228.47M 88.52M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -296.43M -232.52M -180.24M -136.91M
Treasury Stock 0.00 -2.00K -2.00K -2.00K
Other Equity Adjustments 5.00K 27.00K 15.00K 0.00
Total Capitalization 41.25M 91.05M 66.81M -26.51M
Total Equity 41.25M 65.86M 48.27M -48.38M
Total Liabilities & Stock Equity 169.82M 112.05M 113.49M 66.56M
Total Common Shares Outstanding 33.64M 32.62M 25.34M 17.23M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 1.06K 1.06K 0.00
Basic Weighted Shares Outstanding 33.18M 30.33M 16.44M 574.07K
Diluted Weighted Shares Outstanding 33.18M 30.33M 16.44M 574.07K
Number of Employees 308 133 131 83
Number of Part-Time Employees 2 0 2 0

PCRX Pacira Pharmaceuticals Inc

Analysts Ratings for PCRX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 5 5 5 5
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

PCRX Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs